Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Fundamental & Clinical Pharmacology|January 22, 2005
Pharmacoepidemiology of anabolic androgenic steroids: a reviewIngemar Thiblin, Anna PeterssonDrug and Alcohol Dependence|August 30, 2005
Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort studyAnna Petersson, Mats Garle, Fredrik Granath, et al.Comprehensive Psychiatry|April 20, 2010
The significance of anabolic androgenic steroids in a Swedish prison populationFia Klötz, Anna Petersson, Orsolya Hoffman, et al.Forensic Science International|March 6, 2007
Violent crime and substance abuse: a medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugsFia Klötz, Anna Petersson, Dag Isacson, et al.Drug and Alcohol Dependence|May 21, 2010
Substance abusers' motives for using anabolic androgenic steroidsAnna Petersson, Johanna Bengtsson, Anette Voltaire-Carlsson, et al.Drug and Alcohol Dependence|September 3, 2005
Toxicological findings and manner of death in autopsied users of anabolic androgenic steroidsAnna Petersson, Mats Garle, Per Holmgren, et al.Journal of Forensic Sciences|March 19, 2004
Nutritional status of deceased illicit drug addicts in Stockholm, Sweden--a longitudinal medicolegal studyJovan Rajs, Anna Petersson, Ingemar Thiblin, et al.International Journal of Antimicrobial Agents|April 23, 2024
Apramycin efficacy against carbapenem- and aminoglycoside-resistant Escherichia coli and Klebsiella pneumoniae in murine bloodstream infection modelsNiels Frimodt-Møller, Jon U Hansen, Michel Plattner, et al.Clinical Pharmacology and Therapeutics|November 5, 2020
Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for ApramycinTomás Sou, Jon Hansen, Edgars Liepinsh, et al.The Journal of Antimicrobial Chemotherapy|January 11, 2019
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumanniiMario Juhas, Emma Widlake, Jeanette Teo, et al.Pageof 2